Skip to main content
USNA $13.37 -1.91%
USNA logo

USNA · Usana Health Sciences Inc

Track USNA — free
$13.37 -0.26 (-1.91%) At close · Aug 14
Market Cap
$247.03M
Shares
18.48M
All earnings calls

Earnings call · FY2024 Q4

Usana Health Sciences Inc Q4 FY2024 Earnings Call

Usana Health Sciences Inc Q4 FY2024 Earnings Call

Concluded Apr 30, 2024
Apr 30, 2024 50 turns
Period
FY2024 Q4
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Hyatt Acquisition 47 Product Innovation and Launches 13 Associate Incentives and Engagement 12 Commercial Team Reorganization 10 Customer Growth Strategy 8 Balance Sheet and Capital Allocation 7

Management tone

Positive

Net tone +45 · moderate hedging

Grounding quotes
  • “We're now full speed ahead with accelerating delivery and execution upon our customer growth strategy.”
  • “Fourth-quarter results that exceeded our expectations. Net sales grew 7% sequentially, and adjusted diluted EPS increased 14%.”
  • “In closing, 2025 is proving to be an exciting year with much work ahead of us.”
  • “These are tweaks to the model, and we're committed to the direct-selling channel.”

Forward guidance

3 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $213.61M -3.4% YoY
Gross margin · derived Q4 82.0% +1.1 pp YoY
Net income · derived Q4 $4.45M -73.4% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Apr 30, 2024

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
Hyatt revenue
2025
$145M – $160M
Cash to be added to balance
near term
$50M – $60M
Capital expenditures as a percent of sales
2025
1% – 1.5%
Full-screen source Call document